About Hepatocyte nuclear factor 3-beta
Hepatocyte nuclear factor 3-beta (FOXA2) is a protein
from Homo sapiens identified by UniProt accession
Q9Y261, 457 residues long.
MolForge cross-references it against 0 known binders and
320 disease associations.
Target properties
| Protein name | Hepatocyte nuclear factor 3-beta |
| UniProt accession | Q9Y261 |
| Gene | FOXA2 |
| Organism | Homo sapiens |
| Length | 457 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (320)
Diseases linked to this target (Open Targets).
- glucose measurement · score 0.48
- fasting blood glucose measurement · score 0.46
- BMI-adjusted fasting blood glucose measurement · score 0.43
- endometrial cancer · score 0.43
- hypothyroidism · score 0.41
- hyperinsulinism · score 0.37
- hypopituitarism · score 0.37
- congenital isolated hyperinsulinism · score 0.37
- non-acquired combined pituitary hormone deficiency · score 0.37
- familial hyperinsulinism · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9Y261-F1 | alphafold | PREDICTED | 56.69 | — |
Amino-acid sequence (457 residues)
MLGAVKMEGH EPSDWSSYYA EPEGYSSVSN MNAGLGMNGM NTYMSMSAAA MGSGSGNMSA GSMNMSSYVG AGMSPSLAGM SPGAGAMAGM GGSAGAAGVA GMGPHLSPSL SPLGGQAAGA MGGLAPYANM NSMSPMYGQA GLSRARDPKT YRRSYTHAKP PYSYISLITM AIQQSPNKML TLSEIYQWIM DLFPFYRQNQ QRWQNSIRHS LSFNDCFLKV PRSPDKPGKG SFWTLHPDSG NMFENGCYLR RQKRFKCEKQ LALKEAAGAA GSGKKAAAGA QASQAQLGEA AGPASETPAG TESPHSSASP CQEHKRGGLG ELKGTPAAAL SPPEPAPSPG QQQQAAAHLL GPPHHPGLPP EAHLKPEHHY AFNHPFSINN LMSSEQQHHH SHHHHQPHKM DLKAYEQVMH YPGYGSPMPG SLAMGPVTNK TGLDASPLAA DTSYYQGVYS RPIMNSS
Explore Hepatocyte nuclear factor 3-beta with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets